Novartis AG (NOVN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 268.06B |
| Enterprise Value | 293.64B |
| P/E Ratio | 23.61 |
| PEG Ratio | -5.26 |
| Price/Sales Ratio | 5.4 |
| Price/Book Ratio | 7.12 |
| Enterprise/Revenue | 6.16 |
| Enterprise/EBITDA | 15.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.3 |
AD
Management Effectiveness
| Return On Assets | 0.1 |
| Return On Equity | 0.3 |
Income Statement
| Revenue | 57.13B |
| Revenue/Share | 28.76 |
| Gross Profit | 42.86B |
| EBITDA | 23.96B |
| Net Income | 14.65B |
| Diluted EPS | 7.49 |
Balance Sheet
| Total Cash | 7.71B |
| Total Cash/Share | 4.05 |
| Total Debt | 49.15B |
| Total Debt/Equity | 1.18 |
| Current Ratio | 0.86 |
| Book Value Per Share | 22.08 |
Price History
| 52-Week Change | 21.69 |
| 52-Week High | 132.68 |
| 52-Week Low | 97.05 |
| Moving Average 50 Days | 121.31 |
| Moving Average 200 Days | 121.03 |
Statistics
| Average Volume | 2.87M |
| Shares Outstanding | 1.9B |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.51 |
| Trailing Annual Dividend Yield | 2.9 |
| Payout Ratio | 0.68 |
| Last Split Factor | 6:5 |
| Last Split Date | October 04, 2023 |
AD
